All the Active Ingredient Drugs
Corticosteroid, Selective β2 Agonist. Fluticasone Propionate 100, 250, 500 mcg, Salmeterol (as xinafoate) 50 mcg. DISKUS 60 x 50/100 μg; 50/250 μg,
50/500 μg. Adults and child.over 12
yrs: 1 inhal. 2 x dly at lowest effect.
inhaledcorticoster. dose. 4 yrs-12 yrs: 1
inhal. x 100 μg 2 x dly.
Regular tmt. reversible and mod.
obstruct. airways dis. (ROAD), asth. in
adult and child. where comb.
(bronchodilat. and inhaled corticosteroid)
reqd. 50/250 μg; 50/500 μg: Also diskus
50/250, 50/500 for symptomat. tmt.
severe COPD (FEV1 <60% predicted
normal), history repeatedexacerbats.
withsignif. sympts.
despite reg. bronchodilat. ther.
C/I: Hypersens.
Selective β2 Agonist. Salmeterol (as xinafoate) 50 mcg. MULTI-DOSE PWDR. INHALER: 60 x 50
μg/inhalation. Adults and child. over 4
yrs: 1 inhal. (50 μg) 2 x dly. Severe
conds. in adults: 2 inhals. (100 μg) 2 x
dly.
Revers. airway obstruct. (incl. noct. asth.
and excercise induced asth.) in pts. req.
long-term reg. bronchodilat. ther, COPD.
Selective β2 Agonist. Salmeterol (as xinafoate) 25 mcg/ actuation. INHALER: 120 doses. Adults and child.
over 4 yrs: 2 inhals. (50 μg) 2 x dly.
Severe conds. in adults: 4 inhals. (100
μg) 2 x dly.
Tmt. reversible airways obstruct. (incl.
noct. asth., excercise induced bronchospasm)
in pts. req. long-term reg.
bronchodilat. ther, COPD.
